Filing Details

Accession Number:
0000874015-20-000172
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-12-17 19:42:41
Reporting Period:
2020-12-15
Accepted Time:
2020-12-17 19:42:41
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
874015 Ionis Pharmaceuticals Inc IONS Pharmaceutical Preparations (2834) 330336973
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
897667 T Stanley Crooke C/O Ionis Pharmaceuticals, Inc.
2855 Gazelle Court
Carlsbad, CA 92010
Exec Chairman Of The Board Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-12-15 39,000 $49.78 600,391 No 4 S Indirect by trust
Common Stock Disposition 2020-12-17 1,407 $50.50 174 No 4 S Indirect by wife
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect by trust
No 4 S Indirect by wife
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 2,021 Direct
Footnotes
  1. Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on January 2, 2020.
  2. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.50 to $50.00, inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc., any security holder of Ionis Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) of this Form 4.
  3. Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person's wife on January 2, 2020.